Need Help?
No Article Versions Notes Found
Cite
Hanna, W.; Barnes, P.; Berendt, R.; Chang, M.; Magliocco, A.; Mulligan, A.M.; Rees, H.; Miller, N.; Elavathil, L.; Gilks, B.; et al. Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada. Curr. Oncol. 2012, 19, 315-323. https://doi.org/10.3747/co.19.1173
Hanna W, Barnes P, Berendt R, Chang M, Magliocco A, Mulligan AM, Rees H, Miller N, Elavathil L, Gilks B, et al. Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada. Current Oncology. 2012; 19(6):315-323. https://doi.org/10.3747/co.19.1173
Chicago/Turabian StyleHanna, W., P. Barnes, R. Berendt, M. Chang, A. Magliocco, A.M. Mulligan, H. Rees, N. Miller, L. Elavathil, B. Gilks, and et al. 2012. "Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada" Current Oncology 19, no. 6: 315-323. https://doi.org/10.3747/co.19.1173
APA StyleHanna, W., Barnes, P., Berendt, R., Chang, M., Magliocco, A., Mulligan, A. M., Rees, H., Miller, N., Elavathil, L., Gilks, B., Pettigrew, N., Pilavdzic, D., & SenGupta, S. (2012). Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada. Current Oncology, 19(6), 315-323. https://doi.org/10.3747/co.19.1173
